Categories

My Cart

Total:
cookie

Cookies Consent

We use cookies to ensure you...

Wegovy

* For illustration purpose only

Wegovy

Short description

Learn more
Commercial Name: Wegovy
Active Ingredient: semaglutide
Production form: injection pen
Utilization: weight loss
Available Dosage: 1mg, 0.5mg

Shipping: EU2EU = all dosages mentioned with EU2EU are shipped inside Europe and garantuee faster time in delivery

Select the product

Wegovy 1 mg (EU) 1 pills 1 pills

1,154.00 €

Wegovy 1 mg (EU) 2 pills 2 pills

2,183.00 €

Wegovy 1 mg (EU) 3 pills 3 pills

3,212.00 €

Wegovy 1 mg (EU) 4 pills 4 pills

4,242.00 €

Wegovy 1 mg (EU) 6 pills 6 pills

6,300.00 €

1154
In Stock

added to cart

Upgrade and save. Add worth of items to cart and get free shipping

200 €
  • Shipping
    avrg. 5-9 days
    Guaranteed delivery time 16 days
  • Payment

Wegovy

Wegovy - Easy Weight Loss? A Hype with Risks

In social media, the injection for weight loss has triggered a real hype. Celebrities like Elon Musk convey how seemingly easy weight reduction with drugs like Wegovy or Ozempic can be. However, the regular use also brings potential health risks that are rarely discussed.

Weight Loss with the Injection - How Does Wegovy Work?

Wegovy and Ozempic, both medications from Novo Nordisk, a Danish pharmaceutical company, contain the active ingredient semaglutide. This is a genetically engineered, long-acting GLP-1 analog and is classified as a GLP-1 receptor agonist. This means it works similarly to the body's own hormone GLP-1. This hormone stimulates the release of insulin in the pancreas, lowers glucagon concentration, delays gastric emptying, and reduces appetite. Thus, semaglutide can support or substitute the function of the body's own hormone.

Wegovy or Ozempic? How Do the Preparations Differ?

Before discussing the differences, it should be noted that the preparations share some commonalities. Both contain the active ingredient semaglutide, which reduces appetite and cravings. Consequently, body weight can be significantly reduced. Additionally, both medications are prescription-only in the EU.

The differences are mainly found in their application areas:

  • Ozempic is exclusively intended for the treatment of type 2 diabetes in adults in Germany. Weight loss is a beneficial side effect.
  • Wegovy is intended to assist people with severe obesity in losing weight. However, it should not be used as a "lifestyle product" but to help individuals who are severely obese and have not yet been diagnosed with diabetes.

Ordering Wegovy Online:

Wegovy requires a prescription. Typically, patients receive a prescription if the following conditions are met:

  • Adults with obesity (initial Body Mass Index (BMI) > 30 kg/m²)
  • Adults with overweight (BMI > 27 kg/m² to < 30 kg/m²) and at least one weight-related comorbidity
  • Adolescents from 12 years with obesity (according to gender- and age-specific growth charts) and a body weight over 60 kg

Weight Loss without Side Effects? The Risks of the Weight Loss Injection

Especially on social media, there may be an impression that preparations like Wegovy offer the ideal path to rapid weight loss. It is explicitly emphasized that weight loss injections are medications that can also have side effects. These include nausea, vomiting, and various gastrointestinal issues. It is also known that headaches may occur more frequently, and vision may be impaired.

Therefore, these medications should only be considered if prescribed by a competent doctor as medically necessary.

There are also various contraindications where the use of these medications is not recommended. Additionally, potential interactions with other medications need to be carefully considered before a prescription is contemplated by the doctor.

If you want to order such a preparation, you should discuss potential interactions with your doctor or pharmacist.

Add Review

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, to

  • Effectiveness

  • Ease of use/handling

  • Price-performance ratio